X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

The important role of antivirals in the fight against COVID-19

By Richard Moscicki, M.D.  |    October 6, 2021
Throughout the COVID-19 pandemic, public health officials have focused their response into four main areas: 1) rapid and accurate testing: 2) contact tracing systems to monitor outbreaks; 3)...   Read More

Understanding Long COVID-19

By Richard Moscicki, M.D.  |    September 29, 2021
The Centers for Disease Control and Prevention (CDC) defines long COVID as health problems lasting four or more weeks after first getting infected with the novel coronavirus, impacting as many as ...   Read More

PhRMA awards $150,000 to community-based projects aimed at tackling inequities in access to COVID-19 testing, vaccines and therapeutics

By Jackie McRae  |    September 21, 2021
The COVID-19 pandemic has widened health disparities, including the gap in average life expectancy and outcomes for many chronic diseases. These inequities in health status and outcomes among...   Read More

A year and a half later: The biopharmaceutical industry remains committed to beating COVID-19

By Joseph Havey  |    September 8, 2021
Since the start of the pandemic, America’s biopharmaceutical companies have worked around the clock to research, develop and manufacture treatments and vaccines to fight COVID-19. Already, we’ve...   Read More

The impact of monoclonal antibodies and COVID-19 recovery

By Andrew Powaleny  |    September 2, 2021
As the United States and world continue to fight the COVID-19 pandemic, America’s biopharmaceutical research companies continue to do our part in fighting this deadly virus. Decades of scientific...   Read More

Recognizing National Immunization Awareness Month

By Richard Moscicki, M.D.  |    August 31, 2021
Vaccines have played a critical role in reducing the spread of, and in some cases, eliminating the threat of many devastating infectious diseases. They are often cited as second only to clean...   Read More

Driving further innovation is critical to global vaccine equity

By Megan Van Etten  |    August 24, 2021
The following is part of a series of Catalyst posts detailing each of the five strategies to advance COVID-19 global vaccine equity – which rely on and benefit from a strong innovation ecosystem.   Read More

Supporting country readiness to boost global vaccine access

By Megan Van Etten  |    August 12, 2021
The following is part of a series of posts detailing each of the five strategies to advance global COVID-19 vaccine equity – which rely on and benefit from a strong intellectual property ecosystem.   Read More

Ensuring global vaccine equity requires eliminating trade and regulatory barriers

By Megan Van Etten  |    August 5, 2021
The following is part of a series of Catalyst posts detailing each of the five strategies to advance COVID-19 global vaccine equity – which rely on and benefit from a strong innovation ecosystem.   Read More

Setting the record straight: Addressing common misconceptions about the COVID-19 vaccine

By Mike Ybarra  |    August 4, 2021
Bolstered by incredible progress in the fight against COVID-19, the biopharmaceutical industry continues to work around the clock to research, develop and manufacture vaccines and therapeutics to...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates